Ventripoint Diagnostics logo

Ventripoint Diagnostics(TSXV) VPT

Market CapCA$18.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-98%
5 Year-81%
1 Year-10%
1 Month+6%
CA$0.10
+0.00%
+0.00Today
Ventripoint Diagnostics last closing stock price
MetricPriceDate
Last closeCAD 0.102026-10-20
Ventripoint Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.76%CAD 0.092026-10-13
1 month+5.56%CAD 0.092026-09-18
3 month-17.39%CAD 0.122026-07-22
Year to date-32.14%CAD 0.142025-12-31
1 year-9.52%CAD 0.112025-10-20
3 year-48.65%CAD 0.192023-10-20
5 year-80.61%CAD 0.492021-10-21
Since inception-97.63%CAD 4.002007-09-21

Ventripoint Diagnostics Financials at a Glance

Market Cap

CA$18.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$147.77K

Net Income (TTM)

-CA$2.32M

EPS (TTM)

-CA$0.02

P/E Ratio

-4.90

Dividend

CA$0.00

Beta (Volatility)

-0.21 (Low)

Price

CA$0.10

Volume

14,001

Open

CA$0.10

Previous Close

CA$0.10

Daily Range

CA$0.10 - CA$0.10

52-Week Range

CA$0.08 - CA$0.19

Estimated Earnings Date

Nov 26, 2026

VPT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

VentriPoint Diagnostics Ltd. is a medical technology company dedicated to developing and commercializing innovative diagnostic tools for cardiovascular disease. The company’s flagship product, the Ventripoint Medical System (VMS), provides advanced imaging solutions that generate precise three-dimensional models of the heart's chambers.

Products and Services
  • Ventripoint Medical System (VMS) for cardiac imaging
  • VMS+ software for processing echocardiogram and MRI data
  • Specialized applications targeting various cardiac conditions
Growth Outlook
  • Expansion into specialized applications for congenital heart disease and cardiotoxicity
  • Increasing demand for advanced cardiac imaging solutions globally
  • Focus on addressing heart complications related to Covid-19
Financial Highlights
  • Recent quarterly revenue of CAD 19,583, showing stability
  • Trailing twelve months (TTM) gross profit margin at 89.55%
  • Operating expenses totaled CAD 527,584 in the latest quarter
VentriPoint Diagnostics Ltd. operates in the healthcare sector, specifically within medical devices, and is headquartered in Toronto, Canada. The company has been actively working to enhance its product offerings and expand its market reach. The VMS technology is designed to provide accurate volumetric and functional measurements, which are crucial for effective diagnosis and treatment of cardiovascular conditions. With a focus on innovation and addressing unmet medical needs, VentriPoint is positioned to capitalize on the growing demand for advanced cardiac imaging solutions. The financial data indicates a commitment to research and development, although the company is currently navigating challenges related to operating expenses and net income. Overall, VentriPoint Diagnostics Ltd. presents an intriguing opportunity for investors interested in the medical technology sector.
AI Generated • Oct 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hugh MacNaught

Website

www.ventripoint.com

Headquarters

Toronto, ON M6P 1T4, CA

VPT Financials

Key Financial Metrics (TTM)

Gross Margin

89.55%

Operating Margin

-1624.48%

Net Income Margin

-1568.50%

Return on Equity

56.40%

Return on Capital

N/A

Return on Assets

-378.80%

Earnings Yield

-20.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$18.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

192.88M

Volume

14.00K

Avg. Volume

110.97K

Financials (TTM)

Gross Profit

CA$132.34K

Operating Income

-CA$2.40M

EBITDA

-CA$1.66M

Operating Cash Flow

-CA$1.92M

Capital Expenditure

-CA$5.00

Free Cash Flow

-CA$1.92M

Cash & ST Invst.

CA$333.63K

Total Debt

CA$2.62M

Ventripoint Diagnostics Performance Analysis

Ventripoint Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 68,167N/A
20232023-12-31CAD 49,183-27.8%
20242024-12-31CAD 95,17293.5%
20252025-12-31CAD 179,92889.1%
Ventripoint Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31-95.9%
Q12026-03-31355.0%
Q22026-06-30N/A
Ventripoint Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.039.5%
20232023-12-31CAD -0.03-0.3%
20242024-12-31CAD -0.030.0%
20252025-12-31CAD -0.02-37.6%
Ventripoint Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3043.0%
Q42025-12-3173.3%
Q12026-03-31-204.7%
Q22026-06-30-1.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$19.58K

N/A

Gross Profit

CA$19.58K

+228.3%

Gross Margin

100.00%

N/A

Market Cap

CA$18.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$1.83M

N/A

Employees

10

N/A

Net Income

-CA$683.00K

+47.0%

EBITDA

-CA$492.82K

+57.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$333.63K

+34.1%

Total Debt

CA$2.62M

+18.0%

Accounts Receivable

CA$0.00

-100.0%

Inventory

CA$94.24K

N/A

Long Term Debt

CA$59.63K

-64.0%

Short Term Debt

CA$2.56M

+24.6%

Return on Assets

-3.79%

N/A

Return on Invested Capital

63.62%

N/A

Free Cash Flow

-CA$614.42K

-12.3%

Operating Cash Flow

-CA$614.42K

-12.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASG.VAurora Spine Corporation
CA$0.12+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$162.96+10.27%
BITOProShares Trust - ProShares Bitcoin ETF
$11.30+2.62%
NFLXNetflix
$65.37-4.83%
SMCISuper Micro Computer
$35.63+9.74%

Questions About VPT

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at CA$0.10 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between CA$0.08 and CA$0.19.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of CA$2.60M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported CA$55.39K in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services